Filter Search


Healthcare-and-Medical


Location Summary Deadline
Portugal Contract Awarded For 251g000131 - Recombinant Factor Vii (several Dosages) recombinant Factor Vii (several Dosages) value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :03/02/2025 estimated Value Excluding Vat :.251g000131 2025-05-25
Portugal Contract Awarded For 251g000096 - Hemostaticos hemostatics (several Dosages) value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :03/02/2025 estimated Value Excluding Vat :.251g000096 - Hemostaticos 2025-05-25
Portugal Contract Awarded For 1032925 Acquisition Exclusive Medicines Daiichi Sankyo - Year 2025 (2) 1032925 Acquisition Exclusive Medicines Daiichi Sankyo - Year 2025 (2) value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :22/01/2 2025-05-25
Portugal Contract Awarded For 251g000128 - Eftrenonacog Alpha (several Dosages) To 2025 eftrenonacog Alfa (several Dosages) To 2025 value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :29/01/2025 estimated Value Excluding Vat :.251g 2025-05-25
Portugal Contract Awarded For 251g000130 - Efmoctococog Alfa (several Dosages) 251g000130 - Efmoctococog Alfa (several Dosages) value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :14/01/2025 estimated Value Excluding Vat :.251g0001 2025-05-25
Portugal Contract Awarded For 1023425 Acquisition Of Sanofi -aventis Exclusive Medicines -alpha -1st Semester 2025 1023425 Acquisition Of Sanofi -aventis Exclusive Medicines -alpha -1st Semester 2025 value Of The Result: winner Selection Date : date Of Conclus 2025-05-25
Portugal Contract Awarded For 1028125 Acquisition Drugs Exclusive Gilead - Bulevitida - Year 2025 1028125 Acquisition Drugs Exclusive Gilead - Bulevitida - Year 2025 value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :21/01/2025 es 2025-05-25
Portugal Contract Awarded For 251g000132 - Recombinant Factor Vii (several Dosages) recombinant Factor Vii (several Dosages) value Of The Result: winner Selection Date : date Of Conclusion Of The Contract :21/01/2025 estimated Value Excluding Vat :.251g000132 2025-05-25
Portugal Contract Awarded For 1055425 Acquisition Exclusive Medicines Alloga Logifarma - Metreleptin - Year 2025 (2) 1055425 Acquisition Exclusive Medicines Alloga Logifarma - Metreleptin - Year 2025 (2) value Of The Result: winner Selection Date : date Of Con 2025-05-25
Bulgaria Contract Awarded For "delivery Of Laboratory Reagents For The Needs Of Mbal Byala Slatina Eood", 2024-2026 By Separate Positions " "delivery Of Laboratory Reagents For The Needs Of Mbal Byala Slatina Eood", 2024-2026 By Lots "delivery Of Laboratory Reagen 2025-05-25
Whats app